【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, September 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, September 2013 14
2.2.1 Tenet Healthcare Prices Private Placement of Notes for US$4.6 Billion 14
2.2.2 Fresenius to Acquire 43 Hospitals from Rhon-Klinikum for US$4.1 Billion 14
2.2.3 Suntory Beverage to Acquire Lucozade and Ribena Brands from GlaxoSmithKline for US$2.1 Billion 15
2.2.4 Aspen Pharmacare to Acquire Thrombosis Brands and Manufacturing Facility from GlaxoSmithKline for US$1.13 Billion 16
2.2.5 AbbVie Enters Into Licensing Agreement with Ablynx for ALX-0061 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, September 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, September 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, September 2013 20
3.1.1 Top M&A Deals in September 2013 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, April 2013 – September 2013 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, September 2013 24
3.2.1 Top Equity Offering Deals in September 2013 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, April 2013 – September 2013 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, September 2013 29
3.3.1 Top PE/VC Deals in September 2013 31
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, September 2013 32
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, September 2013 34
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, April 2013-September 2013 36
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, April 2013-September 2013 38
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, September 2013 39
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, September 2013 39
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, April 2013 – September 2013 41
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), September 2013 43
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, September 2013 44
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), April 2013 – September 2013 45
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, April 2013 – September 2013 47
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), April 2013 – September 2013 48
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), April 2013 – September 2013 50
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2013 52
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2013 52
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2013 54
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, September 2013 56
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, September 2013 56
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, September 2013 57
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), April 2013 – September 2013 58
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), April 2013 – September 2013 60
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), April 2013 – September 2013 62
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), April 2013 – September 2013 64
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 66
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, September 2013 66
6.1.1 Oncology – Deals of the Month 68
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, September 2013 70
6.2.1 Central Nervous System – Deals of the Month 71
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, September 2013 72
6.3.1 Infectious Diseases – Deals of the Month 74
6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, September 2013 75
6.4.1 Immunology – Dealsof the Month 77
6.5 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, September 2013 78
6.5.1 Respiratory – Deal of the Month 80
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, September 2013 81
6.6.1 Cardiovascular – Deal of the Month 83
6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, September 2013 84
6.7.1 Metabolic Disorders – Deal of the Month 86
7 Deal Summary by Geography 87
7.1 Pharmaceuticals & Healthcare, North America Deals, September 2013 87
7.1.1 North America – Deals of the Month 89
7.2 Pharmaceuticals & Healthcare, Europe, Deals, September 2013 92
7.2.1 Europe – Deals of the Month 94
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, September 2013 96
7.3.1 Asia-Pacific – Deals of the Month 98
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, September 2013 99
7.4.1 Rest of the World – Deals of the Month 100
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 101
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, April 2013 – September 2013 101
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, April 2013 – September 2013 103
9 Further Information 105
9.1 Methodology 105
9.2 About GlobalData 106
9.3 Disclosure information 107
9.4 Disclaimer 107
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：September 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for September 2013 in Pharmaceuticals
■ 発行日：2013年10月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403162558
■ 調査対象地域：グローバル
- 濃縮ジュースの世界市場：果物ジュース、野菜ジュースThe global juice concentrates market has grown exponentially in the last few years. The market size is projected to reach USD 93.94 Billion by 2021, at a CAGR of around 6.0% from 2016 to 2021. Emerging countries such as India and China are the primary targets of this industry. Increasing demand for convenience food & beverages, health consciousness of people in the developing regions, and the use …
- 世界の医薬品卸売及び流通市場：地域別分析、主要企業分析Trends and revenue potentials for distributing and wholesaling of medicines Where’s the drug wholesaler and distribution (W&D) market heading? Discover revenue predictions there to 2024. Also find trends in business and technology, assessing prospects and opportunities to help your work and benefit your influence. In visiongain’s new report you gain sales forecasts there at overall world market, s …
- ホルモン補充療法（HRT）の世界市場：エストロゲン補充療法、成長ホルモン補充療法[Global Hormone Replacement Therapy Market 2015-2019] Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route of administration (oral, parenteral, and transdermal), and by geography (the Americas, EMEA, and APAC). The report also presents the vendor land …
- 自動車用ポジティブクランクケース換気（PCV）バルブの世界市場2019-2023Global Automotive Positive Crankcase Ventilation (PCV) Valve Market: About this market Technavio’s automotive positive crankcase ventilation (PCV) valve market analysis considers sales from both aftermarket and OEM. Our analysis also considers the sales of automotive positive crankcase ventilation (PCV) valve in APAC, Europe, North America, South America, and MEA. In 2018, the aftermarket segment …
- 低床式トレーラー（LBT）の世界市場2017-2021ABSTRACTAbout Low-Bed Trailer A low bed trailer is one of the many types of semi-trailers and is used for versatile applications and to carry loads that are up to 12 feet high, which other trailers cannot accommodate. It is mainly used to carry oversized cargo, including bulldozers and industrial equipment. The global low bed trailer market in the report has been segmented based on the axle type: …
- ブラジル/ロシア/インド/中国の電気生理学（Electrophysiology）処置動向（～2020）BRIC Electrophysiology Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Electrophysiology Procedures Outlook to 2020", provides key procedures data on the BRIC Electrophysiology Procedures. The report provides procedure volumes within market category – Electrophysiology Ablation Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epid …
- デジタル資産管理ソリューションの世界市場：ビデオ管理、ブランドポータル、アセット&メタデータアーカイビング、ウェブコンテンツ管理統合、クリエイティブツール統合、アセットアナリティクス、ライフサイクル&権利管理The Digital Asset Management (DAM) market is estimated to grow from USD 1.42 Billion in 2015 to USD 5.36 Billion by 2020. The DAM market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) of 30.4% because of the increasing need of digital marketing solution and applications among enterprises for various purposes such as asset analytics, and lifecycle and rights management. Oth …
- 船舶用潤滑油の世界市場About Marine LubricantsMarine lubricants are substances that reduce friction and wear at the interface of two materials. It helps in reducing the adhesive friction by lowering the shear strength of interface. Technavio’s analysts forecast the global marine lubricants market to grow at a CAGR of 2.44% during the period 2017-2021. [Covered in this report] The report covers the present scenario and t …
- Amitifadine (大うつ病性障害)：医薬品市場予測及び分析（～2023）Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries …
- コールドチェーン物流の世界市場：エンドユーズ産業別、Cold chain logistics is a temperature-controlled supply chain that is an uninterrupted chain of distribution and storage activity in which a given temperature is maintained throughout the chain. This type of logistics is used to ensure and extend the life of the goods and products such as seafood, frozen food, agriculture produce, chemicals, photographic film, pharmaceutical drugs, and others. Mon …
- 熱可塑性複合材料の世界市場：製品別、エンドユーザー別、樹脂タイプ別、ファイバータイプ別、地域別Global Thermoplastic Composites Market: About this market Technavio’s thermoplastic composites market analysis considers sales from aerospace and defense, consumer goods and electronics, automotive, construction, wind energy, and other end-users. Our study also finds the sales of thermoplastic composites in APAC, Europe, MEA, North America, and South America. In 2019, the aerospace and defense seg …
- アジア太平洋の移動式クレーン市場2016-2020About Mobile Crane Mobile cranes are used to lift and transport different types of load at construction sites. They are mounted on a rubber-tire or crawler carrier and can be powered by electric motors or internal combustion engines. The mobile crane market in APAC is one of the steadily growing construction equipment markets in the world. Technavio’s analysts forecast the mobile crane market in A …
- 世界の屋内LBS市場動向（2012-2016）TechNavio's analysts forecast the Global Indoor Location-based Service (LBS) market to grow at a CAGR of 40.05 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of local area networks. The Global Indoor LBS market has also been witnessing the increasing deployment of indoor LBS solutions in universities. However, the low-level a …
- 転移性移行尿路上皮癌：グローバル臨床試験レビュー（2014年上半期）Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Transitional (Urothelial) Tract Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical t …
- マイクログリッドの世界市場2015-2019About Microgrid A microgrid is a type of power grid, which is much smaller than the conventional centralized electrical grid. It is localized and functions autonomously or in a hybrid mode with the conventional grid. Microgrids produce, distribute, and control the flow of energy to consumers; however, all these activities are implemented locally or in integration with the traditional grid. Microgr …
